Non-Coding mRNA: Merck & Co' Novel Drug Target For Antibacterials And Possibly Human Disease
This article was originally published in Scrip
Executive Summary
Merck & Co researchers have found a small-molecule modulator of non-coding elements in bacterial mRNA that points the way to the development of new antibacterials with a totally new mode of action, and possibly novel medicines for human disease too.